PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...
Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
Morning Overview on MSN
A new compound from ETH Zurich cut nerve-cell loss in mice with Alzheimer’s
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results